论文部分内容阅读
盐酸多柔比星脂质体注射液的研制主要完成人:李春雷王金戌单保恩李彦辉梁敏王彩霞杨汉煜郭文敏张兰高玉清主要完成单位:石药集团中奇制药技术(石家庄)有限公司盐酸多柔比星脂质体注射液是由石药集团中奇公司历经10年自主开发的高端纳米药物(商品名:多美素)。多美素相对于盐酸多柔比星普通制剂,不仅显著降低了心脏毒性和骨髓抑制等不良反应,而且可靶向肿瘤组织,提高疗效,已成为治疗多种肿瘤的一线
Development of Doxorubicin Hydrochloride Liposomal Injection Main Completed by: Li Chunlei Wang Jinxu Dan Baoan Li Yanhui Liang Min Wang Caixia Yang Hanyu Guo Wenmin Zhang Lan Gao Yuqing Major Completed by: SINOPEC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. Rupiah Liposome Injection is a high-end nanometer drug (trade name: Dumexu) developed independently by Zhongqi Company of Shijiazhuang Pharmaceutical Group for 10 years. Dumexu relative to the ordinary preparation of doxorubicin hydrochloride, not only significantly reduced cardiac toxicity and bone marrow suppression and other adverse reactions, but also targeted tumor tissue and improve efficacy, has become the first line of treatment of multiple tumors